Life-saving Treatment With Dry-plasma for Massive Bleeding in an Pre-hospital Setting

ConditionsBleeding Aortic Rupture Gastrointestinal Hemorrhage Obstetric Bleeding Blunt Injury Penetrating Injury

Trial statusNot yet recruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age18+

SponsorVastra Gotaland Region

About this trial

The overall goal of this clinical trial is to study how prehospital transfused dry plasma affect outcomes in terms of mortality as well as complications and coagulation status of patients in or about to develop bleeding shock.

Researchers will compare dry plasma to standard care to see if dry plasma improves survival compared to crystalloid fluid in prehospital patients with heavy bleeding.

Eligibility criteria

Qualifiers

Patients with clinical signs of bleeding which also triggers resuscitation with crisalloids acording to standard care protocol.

Disqualifiers

Patients < 18 years of age.

Patients who lack clinical signs of major bleeding.

Trial design

Treatments tested in this trial

Dry plasma

Treatment groups

650 Participants

are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Vastra Gotaland Region

Lead sponsor

Source ClinicalTrials.gov